Preamble Found Limiting Where It Supplied Antecedent Basis for Other Claim Limitations
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
SHOES BY FIREBUG LLC v. STRIDE RITE CHILDREN'S GROUP
Before Lourie, Moore, and O’Malley. Appeal from the Patent Trial and Appeal Board.
Summary: In similar claims of two related patents, one preamble was limiting because it supplied antecedent basis for a subsequent structural claim limitation, and another preamble that supplied no antecedent basis was not limiting.
Firebug sued Stride Rite for infringing two patents related to footwear illumination systems. In response, Stride Rite petitioned for inter partes review of all asserted claims. After instituting review, the Board held the challenged claims unpatentable as obvious. Firebug appealed, arguing that the Board erred by construing the preambles of the challenged independent claims as non-limiting. Specifically, Firebug asserted that the term “textile” in the preamble phrase “internally illuminated textile footwear” limited the claims and distinguished them from the prior art.
Addressing the first patent, the Federal Circuit noted that the body of the independent claim reintroduced “a footwear” immediately after the preamble and the claim recited a structurally complete invention without the preamble. Thus, the preamble was not limiting. In contrast, the independent claim of the second patent did not reintroduce “footwear” after the preamble and instead relied on the preamble phrase “textile footwear” for antecedent basis in a subsequent structural claim limitation. Thus, the preamble in the second patent was limiting.
Although the Board erred by construing the second preamble as non-limiting, the Federal Circuit deemed the error harmless because the Board found that the prior art also disclosed the use of “textile” footwear, and that finding was supported by substantial evidence. Thus, the Federal Circuit affirmed the Board’s decisions on both patents.
Editor: Paul Stewart
Written by: Aaron S. Johnson & Jeremy Anapol
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…